{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:20:28Z","timestamp":1783045228514,"version":"3.54.6"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81,273,262"],"award-info":[{"award-number":["81,273,262"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.intimp.2026.116730","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:17:05Z","timestamp":1777591025000},"page":"116730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["MAL\/SPP1 axis drives tumor proliferation and immune evasion via JAK2\/STAT3 and MHC class Ib in breast cancer"],"prefix":"10.1016","volume":"181","author":[{"given":"Luping","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxue","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2026.116730_bb0005","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.intimp.2026.116730_bb0010","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.drudis.2022.01.010","article-title":"Triple-negative breast cancer brain metastasis: an update on druggable targets, current clinical trials, and future treatment options","volume":"27","author":"Nakhjavani","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.intimp.2026.116730_bb0015","article-title":"Advances in drugs targeting lymphangiogenesis for preventing tumor progression and metastasis","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116730_bb0020","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/cncr.34084","article-title":"Regulatory t cells: their role in triple-negative breast cancer progression and metastasis","volume":"128","author":"Malla","year":"2022","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.116730_bb0025","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s12672-025-01848-1","article-title":"Long non-coding RNA involved in the carcinogenesis of human female cancer - a comprehensive review","volume":"16","author":"Afroze","year":"2025","journal-title":"Discov. Oncol."},{"issue":"6282","key":"10.1016\/j.intimp.2026.116730_bb0030","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.aaf2784","article-title":"Metastasis as an evolutionary process","volume":"352","author":"Turajlic","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.intimp.2026.116730_bb0035","doi-asserted-by":"crossref","DOI":"10.1590\/0102-6720202500006e1875","article-title":"Peritumoral budding as a predictor for lymph node metastases in colorectal carcinomas: What is the importance?","volume":"38","author":"Santos","year":"2025","journal-title":"Arq. Bras. Cir. Dig."},{"issue":"7","key":"10.1016\/j.intimp.2026.116730_bb0040","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1073\/pnas.84.7.1997","article-title":"CDNA cloning and sequence of MAL, a hydrophobic protein associated with human t-cell differentiation","volume":"84","author":"Alonso","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.intimp.2026.116730_bb0045","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0968-0004(02)02229-6","article-title":"MARVEL: a conserved domain involved in membrane apposition events","volume":"27","author":"S\u00e1nchez-Pulido","year":"2002","journal-title":"Trends Biochem. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2026.116730_bb0050","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1091\/mbc.10.10.3435","article-title":"MAL, an integral element of the apical sorting machinery, is an itinerant protein that cycles between the trans-Golgi network and the plasma membrane","volume":"10","author":"Puertollano","year":"1999","journal-title":"Mol. Biol. Cell"},{"issue":"52","key":"10.1016\/j.intimp.2026.116730_bb0055","doi-asserted-by":"crossref","first-page":"49337","DOI":"10.1074\/jbc.M106882200","article-title":"MAL mediates apical transport of secretory proteins in polarized epithelial Madin-Darby canine kidney cells","volume":"276","author":"Mart\u00edn-Belmonte","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.intimp.2026.116730_bb0060","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1091\/mbc.e07-02-0096","article-title":"Exogenous MAL reroutes selected hepatic apical proteins into the direct pathway in WIF-B cells","volume":"18","author":"Ramnarayanan","year":"2007","journal-title":"Mol. Biol. Cell"},{"issue":"22","key":"10.1016\/j.intimp.2026.116730_bb0065","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1038\/sj.onc.1206378","article-title":"MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the fas pathway","volume":"22","author":"Mimori","year":"2003","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.intimp.2026.116730_bb0070","first-page":"344","article-title":"Suppression of MAL gene expression in gastric cancer correlates with metastasis and mortality","volume":"104","author":"Kurashige","year":"2013","journal-title":"Fukuoka Igaku Zasshi"},{"issue":"5","key":"10.1016\/j.intimp.2026.116730_bb0075","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/onc.2013.580","article-title":"Global identification of genes targeted by DNMT3b for epigenetic silencing in lung cancer","volume":"34","author":"Teneng","year":"2015","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.intimp.2026.116730_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227634","article-title":"Restoration of mal overcomes the defects of apoptosis in lung cancer cells","volume":"15","author":"Yang","year":"2020","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.intimp.2026.116730_bb0085","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12967-022-03254-5","article-title":"MAL protein suppresses the metastasis and invasion of GC cells by interfering with the phosphorylation of STAT3","volume":"20","author":"Geng","year":"2022","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.intimp.2026.116730_bb0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/PAS.0000000000000771","article-title":"Performance of a commercially available MAL antibody in the diagnosis of primary mediastinal large B-cell lymphoma","volume":"41","author":"Gentry","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116730_bb0095","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1309\/98KLHRDAM5CMDHE2","article-title":"MAL is expressed in a subset of hodgkin lymphoma and identifies a population of patients with poor prognosis","volume":"125","author":"Hsi","year":"2006","journal-title":"Am. J. Clin. Pathol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116730_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189461","article-title":"STAT3 axis in cancer and cancer stem cells: from oncogenesis to targeted therapies","volume":"1880","author":"Godugu","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"4","key":"10.1016\/j.intimp.2026.116730_bb0105","doi-asserted-by":"crossref","DOI":"10.3892\/or.2026.9074","article-title":"Regorafenib and nifuroxazide exert enhanced suppression of hepatocellular carcinoma by inhibiting STAT3 and immune remodeling","volume":"55","author":"Li","year":"2026","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2026.116730_bb0110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s13287-024-03810-4","article-title":"Hypoimmunogenic human iPSCs expressing HLA-G, PD-L1, and PD-L2 evade innate and adaptive immunity","volume":"15","author":"Tsuneyoshi","year":"2024","journal-title":"Stem Cell Res. Ther."},{"issue":"10","key":"10.1016\/j.intimp.2026.116730_bb0115","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/s41590-022-01315-x","article-title":"In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer","volume":"23","author":"Dubrot","year":"2022","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116730_bb0120","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116730_bb0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.intimp.2026.116730_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10606","article-title":"An engineered niche delineates metastatic potential of breast cancer","volume":"9","author":"Orbach","year":"2024","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.intimp.2026.116730_bb0135","first-page":"1970","article-title":"Effects of melatonin and doxorubicin on primary tumor and metastasis in breast cancer model","author":"Tanriover","year":"2021","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.intimp.2026.116730_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120370","article-title":"Glucagon-like peptide-1 receptor activation by liraglutide promotes breast cancer through NOX4\/ROS\/VEGF pathway","volume":"294","author":"Liu","year":"2022","journal-title":"Life Sci."},{"issue":"509","key":"10.1016\/j.intimp.2026.116730_bb0145","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw8412","article-title":"Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials","volume":"11","author":"Lin","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"5\u20136","key":"10.1016\/j.intimp.2026.116730_bb0150","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/1947601913496813","article-title":"Transgenic mammary epithelial osteopontin (spp1) expression induces proliferation and alveologenesis","volume":"4","author":"Hubbard","year":"2013","journal-title":"Genes Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.116730_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11010197","article-title":"Osteopontin and cancer: insights into its role in drug resistance","volume":"11","author":"Hao","year":"2023","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.intimp.2026.116730_bb0160","article-title":"Autophagy-induced NR2F1 activation promotes the apoptosis of lens epithelial cells and facilitates cataract-associated fibrosis through targeting STAT3","volume":"12","author":"Zuo","year":"2025","journal-title":"Genes Dis"},{"issue":"23","key":"10.1016\/j.intimp.2026.116730_bb0165","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1002\/cam4.4840","article-title":"SPP1 promotes radiation resistance through JAK2\/STAT3 pathway in esophageal carcinoma","volume":"11","author":"Wang","year":"2022","journal-title":"Cancer Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.116730_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-04806-9","article-title":"Osteopontin promotes hepatocellular carcinoma progression through inducing JAK2\/STAT3\/NOX1-mediated ROS production","volume":"13","author":"Wu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"13","key":"10.1016\/j.intimp.2026.116730_bb0175","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.onc.1205260","article-title":"Constitutive stat3 activity up-regulates VEGF expression and tumor angiogenesis","volume":"21","author":"Niu","year":"2002","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.intimp.2026.116730_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-024-07021-w","article-title":"ETHE1 dampens colorectal cancer angiogenesis by promoting TC45 dephosphorylation of STAT3 to inhibit VEGF-A expression","volume":"15","author":"She","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.116730_bb0185","article-title":"Single-cell transcriptomics and functional validation revealed PLEKHA5-L as a promoter of growth and migration in brain metastatic melanoma cells","volume":"15","author":"Tang","year":"2025","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116730_bb0190","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/s41467-024-45083-8","article-title":"MHC-I upregulation safeguards neoplastic t cells in the skin against NK cell-mediated eradication in mycosis fungoides","volume":"15","author":"Chang","year":"2024","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.intimp.2026.116730_bb0195","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1073\/pnas.1918950117","article-title":"Regulatory CD8 t cells that recognize qa-1 expressed by CD4 t-helper cells inhibit rejection of heart allografts","volume":"117","author":"Choi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.intimp.2026.116730_bb0200","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.humimm.2018.05.003","article-title":"10-year experience with HLA-G in heart transplantation","volume":"79","author":"Lazarte","year":"2018","journal-title":"Hum. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116730_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111929","article-title":"Spatial and single-cell transcriptomics decipher the cellular environment containing HLA-G+ cancer cells and SPP1+ macrophages in colorectal cancer","volume":"42","author":"Ozato","year":"2023","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.intimp.2026.116730_bb0210","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ccell.2023.01.001","article-title":"Immune checkpoint HLA-E: CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.intimp.2026.116730_bb0215","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s13287-025-04461-9","article-title":"Human iPSC-derived NK cells armed with CCL19, CCR2B, high-affinity CD16, IL-15, and NKG2D complex enhance anti-solid tumor activity","volume":"16","author":"Fukutani","year":"2025","journal-title":"Stem Cell Res. Ther."},{"issue":"11\u221212","key":"10.1016\/j.intimp.2026.116730_bb0220","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1007\/s10495-023-01870-0","article-title":"MicroRNA-944 inhibits breast cancer cell proliferation and promotes cell apoptosis by reducing SPP1 through inactivating the PI3K\/Akt pathway","volume":"28","author":"Zhang","year":"2023","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.intimp.2026.116730_bb0225","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12943-023-01931-7","article-title":"Deciphering tumor microenvironment: CXCL9 and SPP1 as crucial determinants of tumor-associated macrophage polarity and prognostic indicators","volume":"23","author":"Su","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.116730_bb0230","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11684-014-0312-8","article-title":"Osteopontin is a promoter for hepatocellular carcinoma metastasis: a summary of 10 years of studies","volume":"8","author":"Qin","year":"2014","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.116730_bb0235","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13058-025-02074-x","article-title":"Cancer-associated fibroblast driven paracrine IL-6\/STAT3 signaling promotes migration and dissemination in invasive lobular carcinoma","volume":"27","author":"Bullock","year":"2025","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.116730_bb0240","doi-asserted-by":"crossref","DOI":"10.1186\/1756-9966-29-51","article-title":"Effects of IL-6 and AG490 on regulation of STAT3 signaling pathway and invasion of human pancreatic cancer cells in vitro","volume":"29","author":"Huang","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.intimp.2026.116730_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041818","article-title":"Cooperative role of thrombopoietin and vascular endothelial growth factor-a in the progression of liver cirrhosis to hepatocellular carcinoma","volume":"22","author":"Vizio","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116730_bb0250","article-title":"Clinical progress of anti-angiogenic targeted therapy and combination therapy for gastric cancer","volume":"13","author":"Xu","year":"2023","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116730_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/2326-6066.CIR-14-0209","article-title":"Tumors: wounds that do not heal-redux","volume":"3","author":"Dvorak","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"12","key":"10.1016\/j.intimp.2026.116730_bb0260","doi-asserted-by":"crossref","first-page":"13225","DOI":"10.1002\/cam4.6014","article-title":"High expression of STAT3 within the tumour-associated stroma predicts poor outcome in breast cancer patients","volume":"12","author":"Morrow","year":"2023","journal-title":"Cancer Med."},{"issue":"5","key":"10.1016\/j.intimp.2026.116730_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27196","article-title":"CAR-NK cells in combination therapy against cancer: a potential paradigm","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.intimp.2026.116730_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.944872","article-title":"Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond","volume":"13","author":"Pagliuca","year":"2022","journal-title":"Front. Immunol."},{"issue":"22","key":"10.1016\/j.intimp.2026.116730_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225572","article-title":"HLA-F allele-specific peptide restriction represents an exceptional proteomic footprint","volume":"20","author":"H\u00f2","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2026.116730_bb0280","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.semcancer.2007.07.005","article-title":"Immune-refractory cancers and their little helpers--an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?","volume":"17","author":"Wischhusen","year":"2007","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.intimp.2026.116730_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02894","article-title":"New insights into the role of QA-2 and HLA-G non-classical MHC-I complexes in malignancy","volume":"9","author":"da Silva","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116730_bb0290","article-title":"Knowledge mapping of tumor microenvironment for breast cancer: a bibliometric analysis from 2014 to 2023","volume":"16","author":"Jiang","year":"2025","journal-title":"Front. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692600576X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692600576X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:04:07Z","timestamp":1783044247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692600576X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":58,"alternative-id":["S156757692600576X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116730","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MAL\/SPP1 axis drives tumor proliferation and immune evasion via JAK2\/STAT3 and MHC class Ib in breast cancer","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116730","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116730"}}